Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #407840 on Amarin Corp Plc (AMRN)
Number sleven
04/28/23 5:07 PM
#407842 RE: ggwpq #407840
Whalatane
04/28/23 5:10 PM
#407843 RE: ggwpq #407840
Diabetes drugs in the GLP-1 agonists class are generally taken by a shot (injection) given daily or weekly and include: Dulaglutide (Trulicity) (weekly) Exenatide extended release (Bydureon bcise) (weekly) Exenatide (Byetta) (twice daily) Semaglutide (Ozempic) (weekly) Liraglutide (Victoza, Saxenda) (daily) Lixisenatide (Adlyxin) (daily) Semaglutide (Rybelsus) (taken by mouth once daily)
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycemic control and body weight reduction.